Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3' to the gene in the promoter of the adjacent convergently transcribed apoC-III gene.

This publication has 13 references indexed in Scilit:

• Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: Genomic, mRNA, and protein sequences with comparisons to other species
  Genomics, 1992
• Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
  Science, 1990
• Transgenic mice containing intestinal fatty acid-binding protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of the reporter gene in their small intestine.
  Proceedings of the National Academy of Sciences, 1988
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
  American Heart Journal, 1987
• High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
  Circulation, 1986
• Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin.
  Proceedings of the National Academy of Sciences, 1985
• Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.
  Proceedings of the National Academy of Sciences, 1985
• Isolation and characterization of the human apolipoprotein A-I gene.
  Proceedings of the National Academy of Sciences, 1983
• Linkage of human apolipoproteins A-I and C-III genes
  Nature, 1983
• Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine.
  Proceedings of the National Academy of Sciences, 1983